SNOAのチャート
SNOAの企業情報
| symbol | SNOA |
|---|---|
| 会社名 | Sonoma Pharmaceuticals Inc （オクルス・イノベイティブ・サイエンス） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Major Pharmaceuticals |
| 業種 | 医薬品 医療関連（Health Care） |
| 概要 | 事業概要 ソノマ・ファーマシューティカルズ(Sonoma Pharmaceuticals Inc.)(旧名:Oculus Innovative Sciences Inc)は皮膚病気と先端ティッシュケア治療用のソリューションの開発・販売に従事する専門製薬会社である。同社の製品ポートフォリオはMicrocynとLipogrid等の技術に基づいた皮膚科学、動物の健康、高度なティッシュケア製品を含む。Microcynは小分子のオキシ塩素化合物を含む液体とゲルで構成される。同社の製品は感染症、かゆみ、痛み、瘢痕及び炎症反応の軽減に応用される。その製品は、米国及び国際的に販売される。 オクルス・イノベイティブ・サイエンスは、米国のヘルスケア企業。処方薬、市販製品を設計、生産、販売する。皮膚科、外科、傷や組織のケア、および動物の医療市場向けの製品を提供する。抗生物質の必要性を低減しつつ、感染症を治療し、治癒を促進するように設計されているMicrocynテクノロジ―と呼ばれる技術プラットフォ―ムを実用化する。 Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care and dermatological conditions. The company's products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma's stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company'sproducts are sold either directly or via partners in 54 countries worldwide and the company actively seeks new distribution partners. The company's principal office is in Woodstock, Georgia, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands. |
| 本社所在地 | 1129 North McDowell Blvd. Petaluma CA 94954 USA |
| 代表者氏名 | James J. Schutz ジェームズ・J.シュッツ |
| 代表者役職名 | President Chief Executive Officer Director 社長兼最高経営責任者（CEO） |
| 電話番号 | +1 707-283-0550 |
| 設立年月日 | 36251 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | ―年 |
| 従業員数 | 225人 |
| url | www.oculusis.com |
| nasdaq_url | https://www.nasdaq.com/symbol/snoa |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -13.85600 |
| 終値（lastsale） | 1.72 |
| 時価総額（marketcap） | 11106358.2 |
| 時価総額 | 時価総額（百万ドル） 11.10636 |
| 売上高 | 売上高（百万ドル） 17.19200 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 3.89936 |
| 当期純利益 | 当期純利益（百万ドル） -14.27800 |
| 決算概要 | 決算概要 BRIEF: For the three months ended 30 June 2018 Sonoma Pharmaceuticals Inc revenues increased 14% to $4.4M. Net loss decreased 1% to $3.5M. Revenues reflect Product increase of 14% to $4.1M Service increase of 18% to $274K. Lower net loss reflects Other income (expense) net increase from $168K (expense) to $51K (income) Interest Income increase of 4% to $55K (income). |
SNOAのテクニカル分析
SNOAのニュース
Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Introduces Podiacyn, an All Natural, Over-the-Counter Podiatry Product for Daily Foot Care 2023/04/11 11:38:00 Finanz Nachrichten
BOULDER, CO / ACCESSWIRE / April 11, 2023 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochloro…
Sonoma Pharmaceuticals Introduces Podiacyn, an All Natural, Over-the-Counter Podiatry Product for Daily Foot Care 2023/04/11 11:30:00 Wallstreet:Online
BOULDER, CO / ACCESSWIRE / April 11, 2023 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of …
Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI North America Conference in Philadelphia 2023/03/28 20:38:00 Finanz Nachrichten
BOULDER, CO / ACCESSWIRE / March 28, 2023 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochloro…
Selling Your Sonoma Pharmaceuticals Inc. (NASDAQ: SNOA) Stock? Here’s What You Need To Know 2023/03/03 16:30:00 Stocks Register
Sonoma Pharmaceuticals Inc. (NASDAQ:SNOA) shares, rose in value on Thursday, 03/02/23, with the stock price up by 4.27% to the previous day’s close as strong demand from buyers drove the stock to $1.22. Actively observing the price movement in the last trading, the stock closed the session at $1.17, falling within a range of $1.12 … Selling Your Sonoma Pharmaceuticals Inc. (NASDAQ: SNOA) Stock? Here’s What You Need To Know Read More »
Sonoma Pharmaceuticals Inc. (NASDAQ:SNOA) stock: You might be surprised 2023/03/02 17:00:00 US Post News
Currently, Sonoma Pharmaceuticals Inc.’s (SNOA) stock is trading at $1.15, marking a fall of -1.71% from last night’s close. At this price, the stock is -72.94% below its 52-week high of $4.25 and 15.00% above its 52-week low of $1.00. Based on the past 30-day period, the stock price is -31.81% below the high and […]
Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Launches Two New Products Expanding Its Line of Office Dispense Products Exclusively for Dermatologists and Medical Spas 2023/01/04 12:38:00 Finanz Nachrichten
BOULDER, CO / ACCESSWIRE / January 4, 2023 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlor…
Sonoma Pharmaceuticals Launches Two New Products Expanding Its Line of Office Dispense Products Exclusively for Dermatologists and Medical Spas 2023/01/04 12:30:00 Wallstreet:Online
BOULDER, CO / ACCESSWIRE / January 4, 2023 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of …
Sonoma Pharmaceuticals GAAP EPS of -$0.33, revenue of $3.3M 2022/11/15 09:30:46 Seeking Alpha
Sonoma Pharmaceuticals press release (SNOA): Q2 GAAP EPS of -$0.33.Revenue of $3.3M (-11.8% Y/Y).EBITDAS loss for the quarter ended September 30, 2022 of $0.6M decreased $0.3M,…
Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Second Quarter 2023 Financial Results 2022/11/14 21:20:00 Finanz Nachrichten
International sales increased by 18% in the six months ended September 30, 2022 compared to the same period prior yearGross profit percentage continues to trend upwards with the quarter ended Septe…
Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday''s Mid-Day Session 2022/11/02 17:28:02 Benzinga
Gainers Starry Group Holdings, Inc. (NYSE: STRY ) gained 56% to $0.2808 after reporting Q3 results. Benefitfocus, Inc. (NASDAQ: BNFT ) shares jumped 47.8% to $10.33 after the company announced it will be acquired by Voya Financial for $10.50 per share. Akso Health Group (NASDAQ: AHG ) gained 44% to $0.7280. Rayonier Advanced Materials Inc. (NYSE: RYAM ) shares climbed 40.9% to $6.30 as the company posted upbeat quarterly results. Forza X1, Inc. (NASDAQ: FRZA ) jumped 39% to $2.3495 after the company announced it received 50 electric boat reservations in the last 90 days, potentially resulting in over $8.5 million in revenue. Bandwidth Inc. (NASDAQ: BAND ) gained 36.9% to $16.84 after the company reported better-than-expected Q3 sales results. The company also issued Q4 and FY22 sales guidance above analyst estimates. Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT ) shares rose 32.8% to $24.30 after the company announced collaboration with CSL to develop and commercialize self-amplifying mRNA vaccines.
Sonoma Pharmaceuticals GAAP EPS of -$0.33, revenue of $3.3M 2022/11/15 09:30:46 Seeking Alpha
Sonoma Pharmaceuticals press release (SNOA): Q2 GAAP EPS of -$0.33.Revenue of $3.3M (-11.8% Y/Y).EBITDAS loss for the quarter ended September 30, 2022 of $0.6M decreased $0.3M,…
Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Second Quarter 2023 Financial Results 2022/11/14 21:20:00 Finanz Nachrichten
International sales increased by 18% in the six months ended September 30, 2022 compared to the same period prior yearGross profit percentage continues to trend upwards with the quarter ended Septe…
Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday''s Mid-Day Session 2022/11/02 17:28:02 Benzinga
Gainers Starry Group Holdings, Inc. (NYSE: STRY ) gained 56% to $0.2808 after reporting Q3 results. Benefitfocus, Inc. (NASDAQ: BNFT ) shares jumped 47.8% to $10.33 after the company announced it will be acquired by Voya Financial for $10.50 per share. Akso Health Group (NASDAQ: AHG ) gained 44% to $0.7280. Rayonier Advanced Materials Inc. (NYSE: RYAM ) shares climbed 40.9% to $6.30 as the company posted upbeat quarterly results. Forza X1, Inc. (NASDAQ: FRZA ) jumped 39% to $2.3495 after the company announced it received 50 electric boat reservations in the last 90 days, potentially resulting in over $8.5 million in revenue. Bandwidth Inc. (NASDAQ: BAND ) gained 36.9% to $16.84 after the company reported better-than-expected Q3 sales results. The company also issued Q4 and FY22 sales guidance above analyst estimates. Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT ) shares rose 32.8% to $24.30 after the company announced collaboration with CSL to develop and commercialize self-amplifying mRNA vaccines.